Forbes June 5, 2023
Topline
Neuralink, Elon Musk’s brain implant company, has won approval from the Food and Drug Administration to start testing its device in humans, one of a growing cadre of neurotech pioneers with goals of merging humans with machines to treat a range of medical conditions such as paralysis, blindness and depression—and enhance existing abilities like memory or allow us to interact with computers by thought alone.
Key Facts
News Peg
In late May, Neuralink announced it had secured FDA approval to launch its first “in-human clinical study.” The decision “represents an important first step that will one day allow our technology to help many people,” the firm said, adding that it was the result of “incredible work” by the Neuralink...